Actual Medicinal Product (AMP) Tranylcypromine 10mg tablets (Pharmaram Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

Protect from moisture and light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Tranylcypromine 10mg tablets (Advanz Pharma).

Generic

Tranylcypromine

Formulation

Tranylcypromine 10mg tablets

Alternative Suppliers (15)

Tranylcypromine 10mg tablets (A A H Pharmaceuticals Ltd)

Tranylcypromine 10mg tablets (Advanz Pharma)

Tranylcypromine 10mg tablets (Alliance Healthcare (Distribution) Ltd)

Tranylcypromine 10mg tablets (DE Pharmaceuticals)

Tranylcypromine 10mg tablets (CST Pharma Ltd)

Tranylcypromine 10mg tablets (Pilsco Ltd)

Tranylcypromine 10mg tablets (Medihealth (Northern) Ltd)

Tranylcypromine 10mg tablets (Rivopharm (UK) Ltd)

Tranylcypromine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Tranylcypromine 10mg tablets (Waymade Healthcare Plc)

Tranylcypromine 10mg tablets (Teva UK Ltd)

Tranylcypromine 10mg tablets (Necessity Supplies Ltd)

Tranylcypromine 10mg tablets (Aristo Pharma Ltd)

Tranylcypromine 10mg tablets (Accord-UK Ltd)

Tranylcypromine 10mg tablets (Pharmaram Ltd)

Related Formulations (1)

Tranylcypromine 10mg tablets